← Leaderboards
Joel R. Haynes
Powderject Vaccines, Inc.
$1,239,823
Attributed
$1,239,823
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,230,920 · 3
By mechanism
P01$1,412,543 · 2
U01$818,377 · 1
Top collaborators
No co-investigators on record.
Most similar at Powderject Vaccines, Inc.
Same institution · by research overlap
- Deborah L. Fuller$17,072,697
Others in their field
Top investigators on “Vector Vaccine”
- Lawrence Corey · Fred Hutchinson Cancer Center$446,547,761
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$142,420,923
- Peter B. Gilbert · Fred Hutchinson Cancer Center$124,587,333
- Louis J. Picker · Oregon Health And Science University$70,366,260
- David Heimbrook · Leidos Biomedical Research, Inc.$68,561,099
Research focus
Vector VaccineCellular ImmunityPatient Oriented ResearchClinical ResearchSwineTransfection /Expression VectorVaccine DevelopmentClinical Trial Phase ICooperative StudyAids VaccinesDisease OutbreaksDrug Screening /EvaluationEnzyme Linked Immunosorbent AssayGene Delivery SystemHemagglutininBiotechnologyHuman SubjectHuman Therapy EvaluationHumoral ImmunityBioterrorism /Chemical WarfareImmunotherapyInfluenza VaccinesLaboratory MouseInfluenzavirus A
Grant awards (5)
Influenza DNA Vaccine for Biodefense/Pandemic Readiness$194,746
U01 · FY2004 · AI
An Adjuvanted Therapeutic DNA Vaccine for AIDS$32,712
P01 · FY2004 · AI
Influenza DNA Vaccine for Biodefense/Pandemic Readiness$623,631
U01 · FY2003 · AI
An Adjuvanted Therapeutic DNA Vaccine for AIDS$388,734
P01 · FY2003 · AI
Adjuvanted DNA Vaccine for Immunotherapy HIV Infection$991,097
P01 · FY2001 · AI